
Biotech venture capital is supposed to be the highest-risk/highest-reward type of investment there is. But many biotech VCs are actually pretty conservative, hesitant to wager on edgy science that might take a decade to pay off.

Biotech venture capital is supposed to be the highest-risk/highest-reward type of investment there is. But many biotech VCs are actually pretty conservative, hesitant to wager on edgy science that might take a decade to pay off.

Maryland Stem Cell Research Commission announced today the launch of Accelerating Cure, a new initiative to support regenerative medicine and cell therapy technologies moving from research to commercialization and finally to clinical trials. Accelerating Cure will fund close to $9 million with its five programs to address the different stages the technologies need to go through. The Commission also announced that Dr. Amritha Jaishankar joined the team as the Award Manager for the Maryland Stem Cell Research Fund.

Kevin Plank’s underdog story has become synonymous with Baltimore — the city his company Under Armour calls home.
Now his investment company, Plank Industries, is looking to rebuild an entire area of the city. Billions of dollars will be poured into Port Covington in one of the largest urban redevelopment projects in the country, which will include housing, retail and an entrepreneurial ecosystem.

Entrepreneur, the magazine that celebrates small business, recently released a list of what they consider to be the 360 best small businesses America has to offer. And wouldn’t you know — some of #dctech’s own were among the companies named.
The list is not meant to showcase only companies that are growing really fast (we see you, Inc.) — it’s more of a congratulations to companies “that keep all their parts growing in harmony.” As such, each company on the list has been evaluated according to the metrics of impact, innovation, growth and leadership.

Sight Machine is a manufacturing analytics company based in the Ann Arbor SPARK Central Innovation Center. It takes all the different resources available to manufacturing companies – quality, ERP systems, etc. – and integrates them into a digital twin of a factory to help stakeholders in the manufacturing process improve quality and efficiency.
The value Sight Machine provides its clients is illustrated in its work with a major global apparel company. For this Fortune 100 Company; it not only automates the process of data collection and analysis, Sight Machine works across a number of factories simultaneously. The intelligence it provides is helping this client resolve issues like debugging over several different locations, offer insight on what’s going on in individual plants, and how similar assets are performing in different locations.
![]()
Bing Yao, PhD, Head of Respiratory, Inflammation and Autoimmunity at MedImmune, spoke with Healio Rheumatology about MedImmune’s collaboration with the University of California at San Francisco, techniques to quantify biomarkers and MedImmune’s role in treating rheumatologic patients.

A great example of a local company giving back to the business community: Montgomery County’s Immunomic Therapeutics, Inc. Founder Dr. Bill Hearl, recently announced the launch of the Immunomic Therapeutics Cancer Discovery Incubator. According to the video announcement posted on YouTube, the incubator “will enable and accelerate ventures, with the capacity for measurable change in oncology health. The goal is to empower the beneficiary to conduct proof-of-concept experiments and ultimately, attract funding partnerships, and fuel growth.” Check out the complete video for further information.

Northrop Grumman Corporation (NOC) and the bwtech@UMBC Cyber Incubator announced today that two more cyber startups – one representing the first international company to participate – have graduated from the Northrop Grumman Cync program. iWebGate of Perth, Australia and Light Point Security of Baltimore have completed the Cync scholarship program.

“Chemistry is the study of matter,” Walter White once opined on Breaking Bad. “But I prefer to see it as the study of change.”
If you take matter (in this case, brick and mortar real estate) and you factor in change (the rising price of this matter), what you’re left with are fewer places to study heady topics like chemistry.

Wed, November 9, 2016 4:00 PM – 7:00 PM EST
Join us for an evening of food, drink, and revelry as we celebrate moving into our new prototyping and manufacturing facility! Tour the new offices and check out the workshop. See what all the buzz is about.
We’ll also have some entertainment for your inner geek. Get an introduction to some of the tools or test your robot driving skills with the “House Bots” from the Baltimore Robotics Center.